Profile and prevalence of aspirin resistance in patients with cardiovascular disease

By 4 June 2019ASPIRIN RESISTANCE
Profile-and-prevalence-of-aspirin-resistance-in-patients-with-cardiovascular-disease

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

Published on 18th May 2013
Profile-and-prevalence-of-aspirin-resistance-in-patients-with-cardiovascular-disease

Joseph S R de Saram CISSP FBCS MIEEE MIScT MINCOSE MACS Snr CP

Information Security Architect / Intelligence Analyst / Computer Scientist / Human Rights Activist / COMSEC / SIGINT / TSCM
893

Joseph S R de Saram CISSP provides thought-provoking insights into Military Intelligence and Law Enforcement, how they operate beyond (as opposed to above) the law, and how their various antics foreseeably lead to the destruction of Fundamental Human Rights. Updates are in progress so check back regularly – verified articles end with . Please feel free to LIKE and SHARE

20130518_000000 JDSSG Borderline ECG Abnormal R and T-waves Dr Victor Lim Parkway Hospital

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

We determined the prevalence and clinical predictors of aspirin resistance by prospectively studying 325 patients with stable cardiovascular disease who were receiving aspirin (325 mg/day for ≥7 days) but no other antiplatelet agents.

Hedding

Enter more text here

Profile-and-prevalence-of-aspirin-resistance-in-patients-with-cardiovascular-disease

Joseph S R de Saram CISSP FBCS MIEEE MIScT MINCOSE MACS Snr CP

Information Security Architect / Intelligence Analyst / Computer Scientist / Human Rights Activist / COMSEC / SIGINT / TSCM
RHODIUM GROUP